HSDT is expected to report earnings to rise 16.67% to -7 cents per share on August 17
Q2'26
Est.
$-0.07
Q2'23
Beat
by $0.06
Q1'23
Beat
by $0.05
Q4'22
Missed
by $0.04
Q3'22
Beat
by $0.09
The last earnings report on August 10 showed earnings per share of -5 cents, beating the estimate of -11 cents. With 98.52K shares outstanding, the current market capitalization sits at 101.59M.
A.I. Advisor
published General Information
General Information
a medical technology company focused on neurological wellness
A.I.dvisor indicates that over the last year, HSDT has been loosely correlated with MLCI. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if HSDT jumps, then MLCI could also see price increases.
The Moving Average Convergence Divergence (MACD) for HSDT turned positive on August 05, 2026. Looking at past instances where HSDT's MACD turned positive, the stock continued to rise in of 42 cases over the following month. The odds of a continued upward trend are .
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on August 07, 2026. You may want to consider a long position or call options on HSDT as a result. In of 81 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
HSDT moved above its 50-day moving average on August 05, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for HSDT crossed bullishly above the 50-day moving average on August 06, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 10 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where HSDT advanced for three days, in of 202 cases, the price rose further within the following month. The odds of a continued upward trend are .
Bearish Trend Analysis
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HSDT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
HSDT broke above its upper Bollinger Band on August 11, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for HSDT entered a downward trend on August 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.513) is normal, around the industry mean (4.199). P/E Ratio (0.005) is within average values for comparable stocks, (27.394). HSDT's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.271). HSDT has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.086). P/S Ratio (7.479) is also within normal values, averaging (17.973).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. HSDT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HSDT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 78, placing this stock worse than average.
